Bioorganic and Medicinal Chemistry Letters p. 4893 - 4898 (2015)
Update date:2022-08-06
Topics:
Cox, Christopher D.
Hostetler, Eric D.
Flores, Broc A.
Evelhoch, Jeffrey L.
Fan, Hong
Gantert, Liza
Holahan, Marie
Eng, Waisi
Joshi, Aniket
McGaughey, Georgia
Meng, Xiangjun
Purcell, Mona
Raheem, Izzat T.
Riffel, Kerry
Yan, Youwei
Renger, John J.
Smith, Sean M.
Coleman, Paul J.
Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia. In order to facilitate preclinical development and support key proof-of-concept clinical trials of novel PDE10A inhibitors, it is critical to discover positron emission tomography (PET) tracers that enable plasma concentration/PDE10A occupancy relationships to be established across species with structurally diverse PDE10A inhibitors. In this Letter, we describe how a high-throughput screening hit was optimized to provide [11C]MK-8193 (8j), a PET tracer that supports the determination of plasma concentration/PDE10A occupancy relationships for structurally diverse series of PDE10A inhibitors in both rat and rhesus monkey.
View MoreContact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Purestar Chem Enterprise Co.,Ltd
website:http://www.purestarchem.com
Contact:05722157374
Address:no235.huanchengdong Rd
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Contact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Doi:10.1016/j.ejmech.2010.07.059
(2010)Doi:10.1002/chem.201000828
(2010)Doi:10.1039/b925562a
(2010)Doi:10.1021/jo00293a049
(1990)Doi:10.1016/j.ica.2010.05.051
(2010)Doi:10.1021/jo1016458
(2010)